Sequencing Antibody Drug Conjugates in Breast Cancer: Exploring Future Roles
Antibody drug conjugates (ADCs) have emerged as a highly effective treatment strategy across breast cancer (BC) subtypes, including human epidermal growth factor receptor 2-positive (HER2+), hormone-receptor positive (ER/PR+), and triple-negative breast cancer (TNBC). Over the past twenty years, ADC...
| Published in: | Current Oncology |
|---|---|
| Main Authors: | , , |
| Format: | Article |
| Language: | English |
| Published: |
MDPI AG
2023-11-01
|
| Subjects: | |
| Online Access: | https://www.mdpi.com/1718-7729/30/12/743 |